COVID-19: UK shows interest in antiviral pill molnupiravir after trial shows it could halve hospitalisations and deaths

The UK has shown interest in an antiviral pill for COVID-19 after "very encouraging" clinical trial results found it cut hospitalisations and deaths by half.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting